Haploidentical donor transplantation
Showing 1 - 25 of 9,855
Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)
Recruiting
- Hematopoietic Organs; Disorder
- CD62L depleted donor lymphocyte infusion
-
Hong Kong, Hong KongHong Kong Children's Hospital
Sep 6, 2023
AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)
Recruiting
- AML
- +2 more
- SOC + TSC-100
- +2 more
-
Hackensack, New Jersey
- +1 more
Aug 11, 2022
Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))
Recruiting
- Hematologic Malignancy
- CD45RA depleted donor lymphocyte infusion (DLI)
-
Tuebingen,, Germany
- +1 more
Jul 13, 2023
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 21, 2022
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation
Not yet recruiting
- Acute Leukemia
- +4 more
- Haploidentical hematopoietic cell transplantation (haploHCT)
- matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
- (no location specified)
Jul 13, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +3 more
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
-
Columbus, Ohio
- +1 more
Apr 20, 2022
Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)
Recruiting
- Aplastic Anemia
- Bone Marrow Failure Syndrome
- Anti-Thymocyte Globulin (Rabbit)
- +8 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 26, 2022
Refractory Acute Myeloid Leukemia Trial in Paris (Sequential Packaging (SET), Transfusion graft, Prevention of GVHD)
Completed
- Refractory Acute Myeloid Leukemia
- Sequential Packaging (SET)
- +4 more
-
Paris, FranceService d'hématologie Clinique Hôpital Saint Antoine
Jul 22, 2022
Donor-recipient ABO Matching on Haploidentical Stem Cell
Completed
- Hematological Malignancies
- Haploidentical Stem Cell Transplantation
- no intervention
-
Hangzhou, Zhejiang, China
- +1 more
Oct 22, 2021
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)
Recruiting
- Sickle Cell Disease
- +4 more
- Blood and Marrow Transplant
-
Minneapolis, MinnesotaMasonic Caner Center at University of Minnesota
May 23, 2022
Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)
Recruiting
- Relapsed Hematologic Malignancy
- donor-derived CIK cells
-
Bergamo, ItalyA O Papa Giovanni XXIII
Dec 22, 2021
Sickle Cell Disease Trial (Haploidentical stem cell transplantation, Standard medical care)
Not yet recruiting
- Sickle Cell Disease
- Haploidentical stem cell transplantation
- Standard medical care
- (no location specified)
May 23, 2022
Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation
Completed
- Leukemia
- +2 more
- CliniMACS Fractionation system (Arm A)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2022
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell
Not yet recruiting
- Hematologic Malignancy
- Haplo-identical Stem Cell Transplantation
- CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
- (no location specified)
Oct 1, 2021
AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)
Recruiting
- AML
- +2 more
- Peripheral blood stem cells
-
Bonn, Germany
- +8 more
Aug 25, 2021
Acute Myeloid Leukemia Trial in Los Angeles (Haploidentical IL-21-Expanded Natural Killer Cells)
Enrolling by invitation
- Acute Myeloid Leukemia
- Haploidentical IL-21-Expanded Natural Killer Cells
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Nov 1, 2021
HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia Trial in Austria, Germany (TCRa/ß+ and CD19+ depleted haploidentical stem
Recruiting
- HbS Disease
- +5 more
- TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation
- Matched sibling donor transplantation
-
Düsseldorf, Germany
- +4 more
Jul 29, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Cyclophosphamide
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 22, 2021
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)
Completed
- Hematological Disease
- +5 more
- Total Body Irradiation 1200 cGy
- +9 more
-
Rochester, New YorkWilmot Cancer Institute
Nov 1, 2021